Duquesne Family Office’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.77M | Hold |
|
|||||
|
2023
Q3 | $3.04M | Hold |
|
|||||
|
2023
Q2 | $4.26M | Hold |
|
|||||
|
2023
Q1 | $4.97M | Hold |
|
|||||
|
2022
Q4 | $6.68M | Hold |
|
|||||
|
2022
Q3 | $6.53M | Hold |
|
|||||
|
2022
Q2 | $7.03M | Hold |
|
|||||
|
2022
Q1 | $6.43M | Hold |
|
|||||
|
2021
Q4 | $9.43M | Hold |
|
|||||
|
2021
Q3 | $13.2M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $22.4M | Hold |
|
|||||
|
2020
Q4 | $26.5M | Buy |
|